Introduction {#s1}
============

Kawasaki disease (KD) is an acute febrile vasculitis syndrome that affects various systems, has an unknown etiology, and generally occurs in children under the age of 5 years old ([@B1]). KD is diagnosed in children who have a prolonged fever for more than 5 days, and five major clinical signs ([@B2]). The vascular involvement of KD occurs in both small and medium-sized blood vessels, particularly the coronary arteries ([@B3]). The most serious complication of KD is a coronary artery lesion (CAL), including myocardial infarction, and coronary artery aneurysms (CAA) ([@B4]). Approximately 20% of untreated children developed a sequelae of vasculitis with a coronary artery aneurysm ([@B5]). A U.S. multicenter study determined that a single high-dose of 2 g/kg intravenous immunoglobulin (IVIG) plus aspirin can lower the incidence of CAA from 20--25% to 3--5%, as well as reduce fever duration ([@B6]).

The global prevalence of KD in children is highest (218/10^5^) in Japan and the lowest (4.7/10^5^) in children of European descent, while Taiwan has an incidence of 66/10^5^ ([@B2]). However, a larger population-based cohort study is required to confirm these observations and determine the clinical characteristics of KD children. Therefore, in the present study, we aimed to examine both the incidence and clinical characteristics of KD patients in a nationwide KD dataset obtained from the health care database of Taiwan\'s National Health Insurance (NHI).

Methods {#s2}
=======

In this study, we used data from the medical claims database of Taiwan\'s National Health Institute (NHI) program. Implemented in Taiwan on March 1, 1995, the NHI program provides compulsory universal health insurance and has information about nearly 99% of the 23.74 million residents of Taiwan based on ethical democratic principles ([@B7]). Previous studies have described in detail the National Health Insurance Research Database (NHIRD) ([@B8], [@B9]), which contains such medical information as insured individuals\' inpatient and outpatient care facilities, prescriptions, gender, date of birth, date of visit or hospitalization, and diagnosis. All diagnoses are coded using the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) format. Information from the NHIRD database has been shown to be complete, reliable, and accurate for use in epidemiological studies ([@B7]).

Children diagnosed with KD (ICD-9: 4461) under the age of 20 years old include untreated KD, KD with aspirin administration, and KD with IVIG administration. Coronary artery aneurysm (CAA) was coded as 414.11 in the ICD-9-CM. We defined KD recurrence as a period of \>1 month between two hospitalizations.

We identified and enrolled a cohort of 13,260 KD patients between January 1997 and December 2011 in this study. All patients were categorized into one of the following three groups: ICD-9+Aspirin, which was defined as patients with two visits within 60 days that received aspirin therapy; ICD-9+IVIG, which was defined as inpatients that received IVIG treatment at diagnosis; and ICD-9 without IVIG, which was defined as inpatients that did not receive IVIG or aspirin treatment. The ICD-9+IVIG group was a specific indicator of KD in the acute stage, while the ICD-9+Aspirin group was a specific indicator of KD in the afebrile stage upon diagnosis. The present study was exempt from full review by Chang Gung Memorial Hospital\'s Institution Review Board (IRB No.102-0364B) because the patients\' identification numbers in the database were encrypted to protect their privacy ([@B10]).

Statistical Analysis
--------------------

The differences between these three KD groups of sex, age group (\<1, ≥1\~ \<2, ≥2\~ \<3, ≥3\~ \<4, ≥4\~ \<5, and ≥5 years-old), and CAA were analyzed by the Pearson chi-square test. The year-specific incidence rates (per 1000 person-y) of KD were calculated by dividing the number of newly diagnosed KD by the total number of children below 5 years of age in Taiwan each year. The annual incidence rate of KD was calculated as the number of KD per 100,000 children \<5 years of age. We performed all analyses using the SAS statistical package (version 9.3; SAS Institute Inc., Cary, NC, USA). Significance was assigned for *p* \< 0.05.

Results {#s3}
=======

Clinical Characteristic of KD
-----------------------------

The purpose of this study was to analyze the general characteristics and annual incidence of KD by collecting patients\' data from the ICD-9+IVIG and ICD-9+Aspirin groups. The study participants\' general characteristics are summarized in [Table 1](#T1){ref-type="table"}. We analyzed 13,260 children diagnosed with KD (ICD-9) under 20 years old in the period between January 1997 and December 2011. Of those, 4614 (35%) were categorized as KD alone (ICD-9), 8394 (63%) as KD with IVIG administration (ICD-9+ IVIG), and 252 (2%) as KD with only aspirin administration (ICD-9+ Aspirin). Of the 8646 patients in the ICD-9+IVIG and ICD-9+ Aspirin groups, the male-to-female ratio was approximately 1.32 (4918/3728), and 8113 (94%) were \<5 years old. The incidence of coronary artery aneurysm (CAA) was 10--12%, with a recurrence rate of 2% in ICD-9+ IVIG and ICD-9+ Aspirin groups and 8% with a recurrence rate of 1% in ICD-9+ IVIG and ICD-9 alone groups. Interestingly, patients in the ICD-9 group without IVIG or aspirin treatment demonstrated no significant gender difference (male-to-female ratio = 1.03), which may indicate that this group was not in the acute stage, was not used for the coronary arteries survey, or was the result of overdiagnosis or misdiagnosis ([@B11]).

###### 

General characteristics of study participants.

                           **Total**     **ICD-9+aspirin**   **ICD-9+IVIG**   **ICD-9**    ***p-value***
  ------------------------ ------------- ------------------- ---------------- ------------ ---------------
  Number of (%) patients   13,260        252 (2)             8,394 (63)       4,614 (35)   
  **GENDER**                                                                               
  Male                     7,264 (55)    156 (62)            4,762 (57)       2,346 (51)   \<0.0001
  Female                   5,996 (45)    96 (38)             3,632 (43)       2,268 (49)   
  **AGE GROUP (%)**                                                                        
  0\~ \<1 y                4,727 (36)    63 (25)             3,117 (37)       1,547 (34)   \<0.0001
  ≥1\~ \<2 y               3,777 (28)    58 (23)             2,504 (30)       1,215 (26)   
  ≥2\~ \<3 y               1,928 (15)    48 (19)             1,220 (15)       660 (14)     
  ≥3\~ \<4 y               1,046 (8)     26 (10)             635 (8)          385 (8)      
  ≥4\~ \<5 y               700 (5)       21 (8)              421 (5)          258 (6)      
  ≥5 y                     1,082 (8)     36 (14)             497 (6)          549 (12)     
  **CAA (%)**                                                                              
  Without                  12,083 (91)   221 (88)            7,593 (90)       4,269 (93)   \<0.0001
  With                     1,177 (9)     31 (12)             801 (10)         345 (8)      
  Recurrent                174 (1)       5 (2)               126 (2)          43 (1)       0.0154

The Seasonality of Kawasaki Disease in Taiwan
---------------------------------------------

[Table 2](#T2){ref-type="table"} shows KD patient distributions by month. In the ICD-9 + IVIG group, the peak months of distribution were April-June, while patient distributions decreased in the winter months (November--February). The monthly distribution trends were similar in children \<5 years old ([Table 3](#T3){ref-type="table"}, [Figure 1](#F1){ref-type="fig"}). The annual incidence rates per 100,000 children \<5 years old are shown in [Table 4](#T4){ref-type="table"}.

###### 

Patient distribution by month of study participants under the age of 20 years old.

  **Month**   **Total**   **ICD-9+aspirin**   **ICD-9+IVIG**   **ICD-9**                    
  ----------- ----------- ------------------- ---------------- ----------- ----- ---- ----- ----
  January     874         7                   16               6           539   6    319   7
  February    945         7                   22               9           584   7    339   7
  March       1,154       9                   28               11          762   9    364   8
  April       1,233       9                   33               13          784   9    416   9
  May         1,357       11                  20               8           881   11   456   10
  June        1,300       10                  23               9           900   11   377   8
  July        1,264       10                  23               9           766   9    475   10
  August      1,183       9                   16               6           700   8    467   10
  September   1,127       9                   21               8           721   9    385   8
  October     1,050       8                   15               6           663   8    372   8
  November    934         7                   16               6           586   7    332   7
  December    839         7                   19               8           508   6    312   7

###### 

Patient distribution by month of study participants under the age of 5 years old.

  **Month**   **Total**   **ICD-9+aspirin**   **ICD-9+IVIG**   **ICD-9**                    
  ----------- ----------- ------------------- ---------------- ----------- ----- ---- ----- ----
  January     793         7                   13               6           501   6    279   7
  February    829         7                   18               8           534   7    277   7
  March       1,056       99                  25               12          714   9    317   8
  April       1,133       9                   26               12          733   9    374   9
  May         1,236       10                  17               8           819   10   400   10
  June        1,213       10                  20               9           860   11   333   8
  July        1,163       10                  20               9           722   9    421   10
  August      1,080       9                   14               6           666   8    400   10
  September   1,046       9                   20               9           678   9    348   9
  October     981         8                   15               7           626   8    340   8
  November    867         7                   13               6           558   7    296   7
  December    781         6                   15               7           486   6    280   7

![The seasonality of Kawasaki disease in Taiwan.](fped-07-00121-g0001){#F1}

###### 

Incidence of study participants under the age of 5 years old.

  **Year**   **Population under 5 y**   **Total**   **ICD-9+aspirin**   **ICD-9+IVIG**   **ICD-9**                    
  ---------- -------------------------- ----------- ------------------- ---------------- ----------- ----- ---- ----- ----
  1997       1599094                    766         48                  12               1           457   29   297   19
  1998       1545889                    983         64                  8                1           569   37   406   26
  1999       1507221                    903         60                  15               1           526   35   362   24
  2000       1489242                    907         61                  11               1           515   35   381   26
  2001       1426759                    964         68                  20               1           632   44   312   22
  2002       1350829                    838         62                  13               1           387   30   438   32
  2003       1309903                    737         56                  14               1           395   30   328   25
  2004       1243939                    800         64                  9                1           406   32   385   31
  2005       1144355                    807         71                  25               2           579   51   203   18
  2006       1092942                    791         72                  16               1           620   57   155   14
  2007       1052585                    718         68                  9                1           528   50   181   17
  2008       1026206                    803         78                  18               2           602   59   183   18
  2009       1002160                    679         68                  15               2           484   49   180   18
  2010       964093                     767         80                  13               1           622   65   132   14
  2011       956990                     715         75                  18               2           575   60   122   13

The increased incidence of KD in recent years in Taiwan

Since the ICD-9+ IVIG and ICD-9+Aspirin groups were diagnosed with KD more accurately in Taiwan\'s NHI health care database, we found that the incidence ranged from 29.3 to 62.0 per 100,000 children from 1997 to 2011 among these patients. The average incidence from 1997 to 2011 was 45.2 per 100,000 children under the age of 5 years old. Overall, the incidence of KD in Taiwan has significantly increased in recent years. We also found that the incidences decreased from 18.6 to 12.8 per 100,000 children from 1997 to 2011 in the ICD-9 alone group, indicating that both the increased accuracy of KD diagnosis and the incidence discrepancy between the two groups were also significant ([Figure 2](#F2){ref-type="fig"}).
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Discussion {#s4}
==========

Today, KD is commonly diagnosed and reported in global populations, especially in Asia ([@B12]). We have observed that the incidence of KD has increased in recent years in Taiwan, as well as in Beijing and Japan ([@B13], [@B14]). Determining whether this observation is the result of increased diagnosis due to improved awareness and/or access to specialist medical services or reflective of an actual increase in incidence is difficult ([@B15]). Both factors likely play a role in many countries, particularly in those countries where KD has been described more recently ([@B16]).

With regard to age, KD generally occurs in children \<5 years old, which represents the turning point of the host\'s immune maturation ([@B15]). Therefore, KD may be associated with the maturing immune system of young children ([@B11]). Furthermore, with regard to gender, our study showed that KD occurs more commonly in the male gender ([@B17]). Overall, KD incidence has increased considerably ([@B18]) with the increased incidence of allergic diseases worldwide ([@B19]). In previous studies, we also discovered that children with KD were at a higher risk of developing atopic dermatitis during the 5 year follow-up period than the control group ([@B10]), as well as for allergic diseases in a population-based matched cohort study ([@B8]).

According to pathologic studies and climatologic studies, the seasonality of KD may be associated with such triggers as environmental factors or infectious pathogens ([@B20]). Our results indicate that the peak months of KD in Taiwan are April, May, and June, which is in line with a previous study that observed an increased incidence of KD in Taiwan during the summer ([@B21]). However, Japan and Korea have been found to have two peaks of seasonal incidence- winter and summer, while the peak incidence of KD in China was observed as spring and summer ([@B22]), with results that resemble those of our study. A global prospective study found that KD case numbers were greater in January through March in the extra-tropic region of the Northern Hemisphere but showed weak significance in seasonal variation in the tropic and the Southern Hemisphere extra-tropics region due to scarce data collection ([@B23]). To explain seasonal variations, Abrams et al. reviewed KD cases from 1991 to 2004 in Japan and suggested that the increased incidence was associated with higher precipitation and lower temperatures in the 2 months prior to disease onset ([@B24]). The hypothesized "tropospheric wind pattern" mechanism helps explain the three major KD epidemic occurrences in Japan, which occurred in 1979, 1982, and 1986. Said seasonal wind may bring the supposed KD agent across the Northern Hemisphere and has allowed scientists to observe the relationship to KD seasonality ([@B25]).

The key to preventing CAL in KD patients is timing the diagnosis and administration of IVIG. In our study, we combined clinical presentations with KD characteristics to develop a five-based mnemonic device for KD that parents and first-line clinicians in clinical diagnosis of KD can easily remember: Fever \>5 days, 5 clinical criteria, predominantly in children \<5 years of age, and peak seasonal clustering in the 5th month, May (April--June). Clinical diagnosis criteria (Kuo Mnemonic: 1-2-3-4-5) include diffuse mucosal inflammation with strawberry tongue and fissure lips (1 mouth), bilateral non-purulent conjunctivitis (2 eyes), unilateral cervical lymphadenopathy (3 fingers check lymph node), indurative angioedema over the hands and feet (4 limbs), dysmorphic skin rashes (5 or more skin rashes) as our previous report ([@B3]).

Our study has some limitations that should be mentioned at this point. First, our study was a single-country study, but the seasonality of epidemiology should be discussed throughout the climate zone. Second, the climate has changed considerably in recent years due to global warming, which may affect seasonal clustering. Furthermore, we did not perform an in-depth analysis of atypical temperature changes, which may have increased the incidence in other months in recent years. Third, data from years ago may under-estimate the incidence of KD due to clinicians\' insufficient education or pediatric medication being less popularized. In the future, we need additional worldwide studies to analyze the epidemiology and seasonal effects of KD.

Conclusion {#s5}
==========

We have observed an increased incidence of KD in recent years, with a higher incidence in children under the age of 5 years old and a seasonal peak during April--June. Based on our clinical presentation, we developed a five-based mnemonic for KD that parents and first-line clinicians in the clinical diagnosis of KD can easily remember: Fever \>5 days, 5 clinical criteria, predominantly in children \<5 years of age, and peak seasonal clustering in the 5th month, May (April--June) in Taiwan.
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